2305 Randomized phase 2/3 trial of transcatheter arterial chemoembolization (TACE) plus sunitinib or placebo in patients with hepatocellular carcinoma (HCC) (PRODIGE 16/SATURNE study): Results of the Phase II part. (September 2015)

• Record Type: Journal Article
• Authors: Hebbar, M.; Heurgue-Berlot, A.; Boige, V.; Le Malicot, K.; Bernard-Chabert, B.; Marcus, C.; Dharancy, S.; Sergent, G.; Perarnau, J.M.; Ehrhard, F.; Ollivier-Hourmand, I.; Vergniol, J.; Michel, P.; Edeline, J.; Rinaldi, Y.; Seitz, J.F.; Lepage, C.; De Baere, T.
• Is Part Of: European journal of cancer. Volume 51:(2015)Supplement 3
• Page Start: S434
• Publication Date: 2015-09
• Subjects: Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Cancer; Tumors; Electronic journals; Periodicals; Electronic journals; 616.994
• DOI: 10.1016/S0959-8049(16)31221-7
• Languages: English
• ISSNs: 0959-8049